Table 1.
Total | Age <60 years | Age ≥60 years | |
---|---|---|---|
1590 (100%) | 664 (41.8%) | 926 (58.2%) | |
Female | 611(38.4%) | 274(41.3%) | 337(36.4%) |
Male | 879 (61.6%) | 390 (58.7%) | 589 (63.6%) |
PS 0 | 522 (32.8%) | 232 (35%) | 290 (31.4%) |
PS1 | 1000 (62.9%) | 408 (61.6%) | 592 (64%) |
PS2 | 65 (4.1%) | 22 (3.3%) | 43 (4.6%) |
Stage IIIB | 205 (12.9%) | 87 (13.1%) | 118 (12.8%) |
Stage IV | 1382 (86.9%) | 576 (86.9%) | 806 (87.2%) |
Wt loss >10% | 182(11.4%) | 79(11.9%) | 103(11.1%) |
PS, performance status on the Eastern Cooperative Oncology Group scale; wt, weight.